Evaluation of Ferumoxytol Enhanced MRI for the Detection of Lymph Node Metastases in Genitourinary (Prostate, Bladder and Kidney) Cancers
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2019
Price : $35 *
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Bladder cancer; Prostate cancer; Renal cancer
- Focus Diagnostic use
- 21 Nov 2018 Status changed from recruiting to completed.
- 12 Oct 2018 Planned primary completion date changed from 30 Sep 2018 to 31 Dec 2018.
- 24 Jan 2018 Planned End Date changed from 30 Dec 2018 to 31 Dec 2018.